The prognosis of MTC is heavily influenced by the stage of the disease, by serum calcitonin and carcinoembryonic antigen levels, and in MEN2 cases by the type of RET mutation [80]. Here, CEACAM5 is linked to medullary thyroid gland carcinoma.